Tixagevimab and Cilgavimab Administration for Hemodialysis Patients at Community-Based Dialysis Centers in Singapore as Pre-Exposure Prophylaxis for SARS-CoV-2 Infection

Introduction: Hemodialysis patients are deemed to be immunosuppressed and may not be able to mount an adequate response to vaccination against the SARS-CoV-2 virus. Due to the higher morbidity and mortality in this vulnerable group, pre-exposure prophylaxis with monoclonal antibodies was introduced...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Behram A, Pagsinohin, Marlyn, Lu, Lucy M, Tan, Pauline, Teo, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394579/
https://www.ncbi.nlm.nih.gov/pubmed/37539406
http://dx.doi.org/10.7759/cureus.41297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394579/
https://www.ncbi.nlm.nih.gov/pubmed/37539406
http://dx.doi.org/10.7759/cureus.41297

Ejemplares similares